Roche’s Ph III cancer immunotherapy trial reveals positive results for liver cancer

Clinical Research |  News | 0 Comment | 18 Dec, 2019

Liver cancer is the fourth most common cancer among men and affects approximately 24 individuals in every 100,000 people...Read more

NeuClone announces Positive Ph I results of Herceptin® (Trastuzumab) Biosimilar

Clinical Research |  News | 0 Comment | 13 Dec, 2019

NeuClone Pharmaceuticals Ltd, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality ...Read more

Takeda presents Phase III Trial results in patients with amyloidosis

Clinical Research |  News | 0 Comment | 09 Dec, 2019

Japan based Takeda Pharmaceutical Company Limited announced the presentation of the results of tourmaline-AL1 trial in a...Read more

CASI Pharma gets China approval Of CNCT19 Clinical Trial Applications

Clinical Research |  News | 0 Comment | 04 Dec, 2019

CASI Pharmaceuticals, Inc., a U.S. biopharmaceutical company focused on developing and commercializing innovative therap...Read more

Seattle Genetics, Astellas announce Clinical Trial collaboration with Merck

Clinical Research |  News | 0 Comment | 03 Dec, 2019

Seattle Genetics, Inc. and Astellas Pharma Inc.have announced a clinical collaboration agreement with Merck, k...Read more

Combination of Immunotherapy and VEGF Inhibitor Improves Survival in HCC

Clinical Research |  News | 0 Comment | 22 Nov, 2019

Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves over...Read more

Trastuzumab Biosimilar HLX02 Met Primary Endpoint in Breast Cancer

Clinical Research |  News | 0 Comment | 22 Nov, 2019

The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epi...Read more

CStone announces first patient dosed in the Phase I study of ivosidenib

Clinical Research |  News | 0 Comment | 20 Nov, 2019

CStone Pharmaceuticals on 20 Nov 2019 announced that the first patient has been dosed in Phase I bridging the registrati...Read more

Roxadustat Phase III study shows positive efficacy in patients with anaemia from CKD

Clinical Research |  News | 0 Comment | 11 Nov, 2019

AstraZeneca and FibroGen Inc. (FibroGen) have presented pooled efficacy and cardiovascular (CV) safety analyses from the...Read more

World first clinical trial commences in alcohol use disorder

Clinical Research |  News | 0 Comment | 28 Oct, 2019

A medication currently used to treat insomnia may also be effective in preventing alcohol intake and relapse in alcohol ...Read more

SCRI honors Clinical Research Coordinators by Distinguished Contributor Award 2019

Clinical Research |  News | 0 Comment | 22 Oct, 2019

The Singapore Clinical Research Institute (SCRI), on 22 Oct 2019, announce the nine winners of the inaugural Distinguish...Read more

ASLAN enrolls first patient to study ASLAN004 targeting Atopic Dermatitis

Clinical Research |  News | 0 Comment | 22 Oct, 2019

ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, announced on 22 Oct 2019, the...Read more

Rentschler Biopharma to expand Japanese operation base

Clinical Research |  News | 0 Comment | 23 Oct, 2019

Germany based Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biop...Read more

ImaginAb inks pact with three global pharma companies

Clinical Research |  News | 0 Comment | 15 Oct, 2019

ImaginAb, Inc., a leading clinical-stage immuno-oncology imaging company has announced the signing of a multi-party coll...Read more

Thermo Fisher expands clinical trials capabilities in China

Clinical Research |  News | 0 Comment | 26 Sep, 2019

Thermo Fisher Scientific, the world leader in serving science, announced an expansion of its integrated clinical trials ...Read more

WCG KMR group invites Biopharma companies to enroll in Clinical Trial Cost Study

Clinical Research |  News | 0 Comment | 20 Sep, 2019

The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announced on 17 Sep 2019 that the enrolme...Read more

Japan's Solasia set to start trials for Darinaparsin

Clinical Research |  News | 0 Comment | 20 Sep, 2019

Solasia Pharma KK has  announced that the darinaparsin Phase 2 study patient registration has reached the targ...Read more

ASLAN presents Ph2 study data for Varlitinib tested on BTC patients

Clinical Research |  News | 0 Comment | 19 Sep, 2019

ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, on 19 Sep 2019 announced late...Read more